PatriciaJ.SulakMD

PubMed

• 117 citations
  Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms
  Patricia J. Sulak, Thomas J. Kuehl, Mirian Ortiz, Bobby L. Shull
  American Journal of Obstetrics and Gynecology. 2002-06-01
• 48 citations
  Evaluation of pituitary–ovarian axis suppression with three oral contraceptive regimens
  Misty A. Vandever, Thomas J. Kuehl, Patricia J. Sulak, Iris Witt, Andrea L. Coffee
  Contraception. 2008-03-01
• 29 citations
  Extended Cycle Combined Oral Contraceptives and Prophylactic Frovatriptan During the Hormone-Free Interval in Women with Menstrual-Related Migraines
  Andrea Coffee, Patricia J. Sulak, Alexandria J Hill, Darci J Hansen, Thomas J. Kuehl
  Journal of Women's Health. 2014-04-07

Journal Articles

• Guidelines for Outpatient Family Planning Care.  
  Sulak PJ, Chez RA, Thorneycroft IH, Monograph for Health Professionals
• A New Way to Manage Menstruation.  
  Sulak PJ, The Female Patient
• Should your patient be on extended use OCs?  
  Sulak PJ, Contemporary OB/GYN
• Using contraceptives to alter bleeding patterns.  
  Sulak PJ, OBG Management
• Adolescent Sexual Health: a matter of having “the facts”.  
  Sulak PJ, OBG Managemen
• Managing perimenopause: the case for OCs.  
  Sulak PJ, OBG Management
• Amenorrhea and Hormonal Contraception.  
  Sulak PJ, Kaunitz AM, Dialogues in Contraception, 2002;7(4):2
• Acceptance of altering the standard 21 day/7 day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms.  
  Sulak PJ, Kuehl TJ, Ortiz M, Shull BL, Am J Obstet Gynecol, 2002;186(6):1142-1149
• OCs: therapeutic uses and quality of life benefits - case presentations.  
  Sulak PJ, Contraception, 1999; 59:35s-38s
• Pessaries: nonsurgical option for prolapse.  
  Sulak PJ, Ob/Gyn News, 1991;26(3):11
• Inadvertent administration of prostaglandin E1 instead of prostaglandin F2 in a patient with uterine atony and hemorrhage.  
  Reedy MB, McMillion JS, Engvall WR, Sulak PJ, Fisher NL, Obstet Gynecol, 1992; 79(5:2);890-894.
• Complexities of adolescence.  
  Sulak PS, Nickel S, Clinical Insights, (Berlex Laboratories, 1992), 5(2):1-6
• Performance of the Sylva direct fluorescent antibody assay for chlamydia in a low-prevalence population.  
  Reedy MB, Sulak PJ, McCombs WB III, Kuehl TJ, Infect Dis in Ob/Gyn, 1993;1:2-6
• Age-related concerns of oral contraceptive use: The perimenopausal patient.  
  Sulak PJ, Int J Fertil, 1994;39(31):158-162
• Combination oral contraceptive pills: How do they differ?  
  Sulak PJ, Coffee AL, Primary Care Update for Ob/Gyns, 1995;2(6):207-211
• Efficacy and safely of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinyl estradiol and 3 milligrams drospirenone.  
  Bachmann G, Sulak P, Benda N, Marr J, Contraception 2004; 70: 191-8
• The use of oral contraceptives to treat common adolescent hormonal disorders.  
  Sulak PJ, Clinical Courier (Scott & White Hospital/Ortho-McNeil Pharmaceuticals), 16(23)
• Review and update on oral contraceptives for the psychiatric practitioner.  
  Coffee AL, Sulak PJ, Medical Update for Psychiatrists, 1998;3:6:213-218
• Evaluating abnormal uterine bleeding.  
  Sulak PJ, OBG Management, August, 1998, 39-46
• Maximizing OC benefits with patient-specific schedules.  
  Sulak PJ, Ob/Gyn Management, 2000;12(8):48-59
• Hyperlipidemia: new territory for the ob/gyn.  
  Goldberg MH, Wild RA, Dickerson, VM, Nolan TE, Sulak PJ, The Female Patient, August, 2000 (Supplement), CME monograph
• Skipping the pill-free interval controls premenstrual symptoms.  
  Sulak PJ, Ob/Gyn News, 2000;35(4):10
• Using OCs to manage perimenopause.  
  Sulak PJ, OBG Management, 2000;Feb:41-50
• Efficacy and safety of a constant estrogen, pulsed progestin regimen in hormone replacement therapy.  
  Sulak PJ, Caubel P, Lane R, Int J of Fertil and Womens Medicine, 1999;44(6):286-296
• Adolescence, sexuality and contraception.  
  Emans SJ, Sulak PJ, Dialogues in Contraception, 1999;6(2):4-8
• Join now to see all

Books/Book Chapters

• Atlas of Clinical Gynecology. 
  Chapter: Dysfunctional Uterine Bleeding: Evaluation and Treatment 
  Sulak PJ, Yandell PMEditors: Stenchever MA, Mishell.
• PERIMENOPAUSE 
  Chapter: Contraceptive Needs and Options in Perimenopausal Women 
  Page 281 - 286Sulak PJEditors: Lobo R.New York
• PerimenopaulsaL Gynecology. 
  Chapter: Creative use of oral contraceptives in the perimenopausal patient 
  Sulak PJParthenon Publishing, NY
• Telindes Operative Gynecology. 
  Chapter: Non-Surgical Correction of Pelvic Support Defects: Use of Vaginal Support Devices (Chapter 38) 
  Sulak PJEditors: John A. Rock and John D.Edition 8,
• Join now to see all

Abstracts/Posters

• Evaluation of the pituitary-ovarian axis suppression with three different oral contraceptive regimens.
  Sulak P, Kuehl T, Coffee A, Vandever M, Reape K, The ACOG ACM, San Diego, CA
• Current Clinical Issues in Oral Contraceptives.
  Sulak PJ, Contemporary Ob/Gyn, 1996; 41(12)(Supp
• Greater Inhibition of the Pituitary Ovarian Axis with a Shortened Hormone Free Interval.
  Willis S, Sulak P, Kuehl T, The Annual ASRM meeting, Philadelphia PA
• Comparison of a 21 / 7 Day Oral Contraceptives Containing 19-Nortestosterone Progestins with a Drospirenone Containing OC.
  Willis S, Sulak P, Kuehl T, The 17th Annual Resident Research Day / Bunkley Day, Scott & White Hospital, Temple Texas
• Efficacy and Safety of a Twenty-Four Day Oral Contraceptive Regimen With Ethinylestradiol (20mcg) and Drospirenone (3mg).
  Bachmann G, Sulak P, Marr J, The ACOG Annual Clinical Meeting, Philadelphia PA
• Analysis of Knowledge and Attitudes of Adult Groups Regarding Adolescent Sexual Health Before and After a Scott and White Worth The Wait Program.
  Sulak P, Kuehl A, Todaro D, Fix D, Kuehl T, Annual Meeting of the Medical Institute, Washington D.C
• Join now to see all

Lectures

• Serum Hormone Levels, Bleeding Patterns, and Symptomatology in a 21/7 Versus Extended Regimen of a Drospirenone Containing Oral Contraceptive. 
  Presented at the 12th Annual Controversies in Gynecology, Venice Italy
• OCs: therapeutic uses and quality of life benefits. The Science of OCs and Todays Clinical Challenges. 
  Scientific Symposium at the American Society for Reproductive Medicine 54th Annual Meeting